androst-5-en-3-ol has been researched along with pregnenolone in 2 studies
| Studies (androst-5-en-3-ol) | Trials (androst-5-en-3-ol) | Recent Studies (post-2010) (androst-5-en-3-ol) | Studies (pregnenolone) | Trials (pregnenolone) | Recent Studies (post-2010) (pregnenolone) |
|---|---|---|---|---|---|
| 12 | 0 | 2 | 4,510 | 36 | 501 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kołek, T | 1 |
| Chodounska, H; Kudova, E; Matousova, M; Mertlikova-Kaiserova, H; Slavikova, B; Soucek, R; Tloustova, E | 1 |
2 other study(ies) available for androst-5-en-3-ol and pregnenolone
| Article | Year |
|---|---|
Biotransformation XLVII: transformations of 5-ene steroids in Fusarium culmorum culture.
Topics: Androstenedione; Androstenols; Biotransformation; Chromatography, Gas; Dehydroepiandrosterone; Fusarium; Hydroxylation; Magnetic Resonance Spectroscopy; Pregnenolone; Steroids | 1999 |
Pregn-5-en-3β-ol and androst-5-en-3β-ol dicarboxylic acid esters as potential therapeutics for NMDA hypofunction: In vitro safety assessment and plasma stability.
Topics: Androstenols; Animals; Autism Spectrum Disorder; Cell Survival; Cholesterol; Dicarboxylic Acids; Drug Stability; Esters; Hep G2 Cells; Humans; Intellectual Disability; Mitochondria; Molecular Structure; Neurons; Neuroprotective Agents; Pregnenolone; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Tumor Cells, Cultured | 2019 |